2021
DOI: 10.1155/2021/9918830
|View full text |Cite
|
Sign up to set email alerts
|

Chemical Gastroenterocolitis after Dental Root Canal Therapy with Camphorated and Mentholated Chlorophenol

Abstract: A 78-year-old man with a history of pancolitis, after the treatment of dental abscess with oral antibiotics and local application of camphorated and mentholated chlorophenol (CMCP), presented with abdominal pain of 4-day duration, as well as hair loss in the area of moustache and finger nail lifting. He was already treated with rectal application of budesonide because of pancolitis, diagnosed 6 weeks ago and interpreted as an allergic reaction to clindamycin. For further investigation, we performed gastroscopy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…The development of hair follicles is a dynamic and cyclic process which determines hair growth and shedding and includes the growing phase (anagen), remodeling phase (catagen), and quiescent phase (telogen) [ 118 , 119 ]. Hair follicles stay in the telogen phase when their growth cycle is disrupted by some triggers, e.g., drugs, stress, surgery, and chronic inflammation, resulting in diffuse hair loss, which is called telogen effluvium [ 120 122 ]. To date, only three cases of hair loss related to the topical application of imiquimod have been reported [ 3 , 122 ].…”
Section: Rare Imiquimod-associated Cutaneous Side Effectsmentioning
confidence: 99%
“…The development of hair follicles is a dynamic and cyclic process which determines hair growth and shedding and includes the growing phase (anagen), remodeling phase (catagen), and quiescent phase (telogen) [ 118 , 119 ]. Hair follicles stay in the telogen phase when their growth cycle is disrupted by some triggers, e.g., drugs, stress, surgery, and chronic inflammation, resulting in diffuse hair loss, which is called telogen effluvium [ 120 122 ]. To date, only three cases of hair loss related to the topical application of imiquimod have been reported [ 3 , 122 ].…”
Section: Rare Imiquimod-associated Cutaneous Side Effectsmentioning
confidence: 99%